Regardless of the advancement, the company's stock has remained mainly flattish over the past fifteen months (with the exception of the latest tumble).   This time they stated the Fusionex Group essential the US£a hundred million to US£150 million funding to bolster its R&D. No mention was product of needing the money to stabilise the group.In